To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis.

ABSTRACT:

Background

Several retreatment strategies exist for rituximab in rheumatoid arthritis (RA). In some countries, reimbursement criteria require a loss of disease control for rituximab retreatment. Understanding the patients' and rheumatologists' perceptions regarding this retreatment strategy would be informative in identifying the optimal treatment administration schedule.

Objectives

This study aimed to uncover patients' and rheumatologists' perceptions regarding retreatment strategies of rituximab.

Design

Qualitative study - semi-structured interviews.

Methods

Patients with RA, treated with rituximab, and rheumatologists were invited to participate in a qualitative study consisting of individual, in-depth, semi-structured interviews. Interviews were analysed ac

SUBMITTER: Bertrand D 

PROVIDER: S-EPMC10903194 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature